PUBLIC COMPANY
saveBaxter Healthcare Corp
updated 4mo ago
Baxter International Inc. is an American multinational healthcare company with headquarters in Deerfield, Illinois.
community read0 votes
🐶 often sniffed alongside
top 8- tagRecall41 co-mentions · 32 sources
- tagDrug Shortage15 co-mentions · 15 sources
- tagAdCom9 co-mentions · 9 sources
- tag510(k) Clearance6 co-mentions · 6 sources
- tagHematology4 co-mentions · 2 sources
- tagPMA Approval3 co-mentions · 3 sources
- tagOphthalmology2 co-mentions · 1 sources
- tagCardiology2 co-mentions · 2 sources
pipeline
16
marketed
9
phase 3
0
catalysts ytd
30
approvals ytd
7
recalls ytd
6
Pipeline(16)
view full pipeline →pipeline depth16 products
9Marketed7Unknown
Marketed
Cytoxan
Nephrotic Syndrome
MarketedDapzura RT
Bacteremia
MarketedIFOSFAMIDE
Germinomatous (Seminomatous) Germ Cell Tumors
MarketedMetroniflex
Bacterial Pneumonia
MarketedNorepinephrine Bitartrate Baxter
Cardiac Arrest
Marketedaprotinin + fibrinogen (human) + thrombin (human)
Hemorrhage
Marketeddesflurane
General Anesthetic Effect
Marketedoxacillin
Staphylococcal Infections
Marketedthrombin (recombinant)
Hemorrhage
drugBREVIBLOC
drugDOXIL (LIPOSOMAL)
drugEPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- N/AGen 2 Battrode Wear Study
- N/ATimmy3 Module Clinical Accuracy ISO 80601-2-56:2017 + A1 2018
- —Mobile Cardiac Telemetry (MCT) Study
- —PMCF Study for COSEAL® in Gynecologic Surgery
- N/AOscillation and Lung Expansion (OLE) Therapy for Treatment of Neuromuscular Disease (NMD) Patients
- phase1A Study Comparing Organic Phosphate (Sodium Glycerophosphate Injection) to Numeta G16%E
- phase1A Bioequivalence Study Comparing Organic Phosphate (Sodium Glycerophosphate Injection) to Inorganic Phosphate (Sodium Phosphates Injection, USP)
- phase1Doxil/Caelyx BE Study
🐶 Hiring Signal
News
- Baxter Issues Voluntary Nationwide Recall for Two Lots of 0.9% Sodium Chloride Injection Due to Potential Presence of Particulate MatterFOR IMMEDIATE RELEASE – AUG. 25, 2026 – DEERFIELD, Ill., Baxter International Inc. (NYSE:BAX) is voluntarily recalling two lots of 0.9% Sodium Chloride Injection due to the potential presence of pa…fda_medwatch · 1mo ago
- Baxter Issues Voluntary Nationwide Recall for One Lot of 70% Dextrose Injection Due to Potential Presence of Particulate MatterFOR IMMEDIATE RELEASE – AUG. 25, 2026 – DEERFIELD, Ill., Baxter International Inc. (NYSE:BAX) is voluntarily recalling one lot of 70% Dextrose Injection due to the potential presence of particulate…fda_medwatch · 1mo ago
- Baxter Issues Voluntary Nationwide Recall for One Lot of Anticoagulant Sodium Citrate Solution Due to Potential Presence of Particulate MatterFOR IMMEDIATE RELEASE – AUG. 25, 2026 – DEERFIELD, Ill., Baxter International Inc. (NYSE:BAX) is voluntarily recalling one lot of Anticoagulant Sodium Citrate Solution due to the potential presence…fda_medwatch · 1mo ago
- Intravascular Administration Set Recall: Baxter Removes Duo-Vent Solution SetsBaxter administration sets may have air bubbles in the drip chamber and tubing, which may result in air being delivered through the IV line to the patient.fda_medwatch · 1mo ago
- After tasting IPO success, Hemab’s CEO seeks ‘flavor of a multi-product coagulation company’With the post-IPO quiet period having come to an end, CEO Benny Sørensen, M.D., Ph.D., was free to sit down with Fierce to map out Hemab’s future.fiercebiotech · 1mo ago
- BAXTER ISSUES VOLUNTARY NATIONWIDE RECALL OF CEFAZOLIN IN DEXTROSE INJECTION, USP, 2G / 100ML (20MG / ML) SINGLE-DOSE INFUSION BAG IN 100ML DUE TO PARTICULATE MATTER FOUND IN SOLUTIONJuly 24, 2026 – DEERFIELD, Ill., Baxter International Inc. (NYSE:BAX) is voluntarily recalling Lot LD175708, Exp 14-Feb 2027 of Cefazolin in Dextrose Injection due to a report of particulate matter…fda_recalls · 2mo ago
- Baxter Issues Voluntary Nationwide Recall of Cefazolin in Dextrose Injection, USP, 2G / 100ml(20mg /ml) Single-Dose Infusion Bag in 100ml Due to Particulate Matter Found in SolutionJuly 24, 2026 – DEERFIELD, Ill., Baxter International Inc. (NYSE:BAX) is voluntarily recalling Lot LD175708, Exp 14-Feb 2027 of Cefazolin in Dextrose Injection due to a report of particulate matter…fda_recalls · 2mo ago
- Early Alert: Intravascular Administration Set Issue from BaxterBaxter administration sets may have air bubbles in the drip chamber and tubing, which may result in air being delivered through the IV line to the patient.fda_medwatch · 2mo ago
Data sources
Found something off?
comments(0)
5-min edit window · permanent after that